BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14566181)

  • 1. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
    Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
    Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy].
    Weber MA; Lichy MP; Thilmann C; Günther M; Bachert P; Maudsley AA; Delorme S; Schad LR; Debus J; Schlemmer HP
    Radiologe; 2003 May; 43(5):388-95. PubMed ID: 12764588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
    Lüdemann L; Warmuth C; Plotkin M; Förschler A; Gutberlet M; Wust P; Amthauer H
    Eur J Radiol; 2009 Jun; 70(3):465-74. PubMed ID: 18359598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced multi-shot echo-planar FLAIR in the depiction of metastatic tumors of the brain: comparison with contrast-enhanced spin-echo T1-weighted imaging.
    Tomura N; Narita K; Takahashi S; Otani T; Sakuma I; Yasuda K; Nishii T; Watarai J
    Acta Radiol; 2007 Nov; 48(9):1032-7. PubMed ID: 17957522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: Arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI.
    Lehmann P; Monet P; de Marco G; Saliou G; Perrin M; Stoquart-Elsankari S; Bruniau A; Vallée JN
    Eur Neurol; 2010; 64(1):21-6. PubMed ID: 20558984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
    Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
    J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results.
    Weber MA; Thilmann C; Lichy MP; Günther M; Delorme S; Zuna I; Bongers A; Schad LR; Debus J; Kauczor HU; Essig M; Schlemmer HP
    Invest Radiol; 2004 May; 39(5):277-87. PubMed ID: 15087722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAIR-TrueFISP imaging of cerebral perfusion in areas of high magnetic susceptibility differences at 1.5 and 3 Tesla.
    Boss A; Martirosian P; Klose U; Nägele T; Claussen CD; Schick F
    J Magn Reson Imaging; 2007 May; 25(5):924-31. PubMed ID: 17410577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients.
    Hunsche S; Sauner D; Schreiber WG; Oelkers P; Stoeter P
    J Magn Reson Imaging; 2002 Aug; 16(2):137-46. PubMed ID: 12203760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
    Ulmer S; Helle M; Jansen O; Mehdorn HM; Nabavi A
    Neuroimage; 2009 Mar; 45(1):38-43. PubMed ID: 19100843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
    Takeda T; Takeda A; Nagaoka T; Kunieda E; Takemasa K; Watanabe M; Hatou T; Oguro S; Katayama M
    Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
    White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
    J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.